AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Roxithromycin in South Africa

6 products registered with SAHPRA — 2 active

Brand / ProductReg. No.HolderStatusExpires
CIPLA-ROXITHROMYCIN 15037/20.1.1/0366Cipla Medpro (Pty) Ltdsuspended18 Jul 2025
ROXXIBID 15037/20.1.1/0367Cipla Medpro (Pty) Ltdsuspended17 Jul 2025
THROSYN 150 mg TABLET36/20.1.1/0424Pharmacare Limited û Woodmeadsuspended15 Jul 2024
ROXIGEN34/20.1.1/0503MERCK GENERICS RSA (PTY) LTDsuspended1 Nov 2022
ROXITHROMYCIN - HEXAL 15035/20.1.1/0222HEXAL PHARMA (SA) (PTY) LTDactive1 Jan 1900
ROXITHROMYCIN - HEXAL 30035/20.1.1/0223HEXAL PHARMA (SA) (PTY) LTDactive1 Jan 1900

Roxithromycin — SAHPRA Registration Details

SAHPRA (South Africa) has 6 registered products containing Roxithromycin, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Roxithromycin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.